AFRICAN Health Ministers have committed to adopting a unified continental position aimed at accelerating efforts to end HIV and AIDS as a public health threat by 2030, amid growing concerns over global funding uncertainties and the future sustainability of HIV programmes.
Read Article
The United States has launched lenacapavir (LEN), the new long-acting HIV prevention drug, in Zimbabwe, with plans to support thousands op poeple.
Read Article
Zimbabwe has taken a decisive step forward in strengthening its national health system with the official commissioning of Nucleic Acid Testing (NAT) for blood screening at the National Blood Service Zimbabwe (NBSZ) headquarters in Harare.
Read Article
Zimbabwe's health authorities on Thursday (19 February) began administering the long-acting injectable HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections. Health Minister Douglas Mombeshora said the programme, funded by the US and the Global Fund, would initially target more than 46,000 people at high risk of contracting HIV across 24 sites nationwide.
Read ArticleCondom distribution, PrEP, and behavior change communication reaching millions across all provinces.
Learn MoreExpanding access to antiretroviral therapy across all provinces with 92% coverage achieved.
Learn MoreSocial Contracting uses domestic and public resources to support Civil Society Organizations (CSOs) that are better positioned to meet national health priorities
Learn MoreMonitoring the epidemic through cutting-edge research to inform evidence-based policy decisions.
Learn More
Highlights from the National AIDS Council Annual General Meeting with key stakeholders.
Blood Bank and Renal Unit support for improved healthcare services.
Commemorations with community engagement and awareness campaigns across Zimbabwe.